Profile for Amgen Inc. (AMGN)

$ 226.91   -2.79 (-1.21%) Volume: 1.82m 4:00 PM EDT 1-Jun-2020
After Hours:  $ 226.75   -0.16 (-0.07%) Volume: 69.78k 7:58 PM EDT 1-Jun-2020
Business Description:
Amgen Inc is a biotechnology company that discovers, develops, manufactures and delivers human therapeutics. The Company's business segment is human therapeutics.
Address: One Amgen Center Drive, Thousand Oaks, CA, USA, 91320-1799
Telephone: +1 805 447-1000 Website:
Facsimile: +1 805 447-1010 Email: [email protected]
CEO: Robert A. Bradway
Employees: 23,400 Market Cap: 133.48b
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 318154
Industry: Drug Manufacturers
Sub-Industry:    Drug Manufacturers - General
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)